|
Evaluating the Impacts of Health Research: Revisiting the Canadian Institutes of Health Research Impact Assessment Framework
|
| Presenter(s):
|
| Nicola Lauzon, Canadian Institutes of Health Research, nicola.lauzon@cihr-irsc.gc.ca
|
| Marc Turcotte, Canadian Institutes of Health Research, marc.turcotte@cihr-irsc.gc.ca
|
| Laura McAuley, Canadian Institutes of Health Research, laura.mcauley@cihr-irsc.gc.ca
|
| Abstract:
The Canadian Institutes of Health Research (CIHR) has a mandate to excel in the creation and translation of knowledge into improved health and a strengthened health care system. To ensure CIHR remains accountable to the public, the measurement of progress towards this ambitious mandate is necessary. Research evaluations are challenging because research outcomes are not directly attributable to research funding, often occur after many years, and are difficult to measure. CIHR's Impact Assessment Framework aims to bridge this divide by considering different spheres of influence and by using a contribution, rather than attribution, approach. As a learning organization, CIHR continually seeks to improve. This paper describes challenges encountered while applying the Framework to the evaluation of health research impacts in SARS, Commercialization, Obesity, and Cardiovascular disease as well as assessments prepared by each of our 13 Institutes. Lessons learned and refinements to the framework will be discussed.
|
|
Evaluating the Commercialization of Technologies Using the Canadian Institutes of Health Research Impact Assessment Framework
|
| Presenter(s):
|
| Marc Turcotte, Canadian Institutes of Health Research, marc.turcotte@cihr-irsc.gc.ca
|
| Laura McAuley, Canadian Institutes of Health Research, laura.mcauley@cihr-irsc.gc.ca
|
| Nicola Lauzon, Canadian Institutes of Health Research, nicola.lauzon@cihr-irsc.gc.ca
|
| Abstract:
The Canadian Institutes of Health Research (CIHR) is Canada's federal health research funding agency. CIHR's ambitious mandate goes beyond the funding of research excellence to include the translation of research knowledge into health and health system benefits for Canadians. Through CIHR's Impact Assessment Framework, we are investigating the contribution of health research to broader impacts in the areas of health and economics. This evaluation explores the translation of research through commercialization of technologies. Two important steps in the commercialization process is patenting of innovative technologies and products, and the creation of spin-off companies. Using data from the United States Patent and Trademark Office together with administrative and interview data we evaluate CIHR's contributions to the process of moving research from an academic setting to the marketplace. This evaluative study will improve our understanding of facilitators, barriers and drivers of commercialization from a health research funder perspective.
|
|
Putting a Value on Biomedical Research Center Programs: Adapting the Research Payback Framework for Application in the United States
|
| Presenter(s):
|
| Jack E Scott, The Madrillon Group Incorporated, jscott@madrillongroup.com
|
| Margaret Blasinsky, The Madrillon Group Incorporated, mblasinsky@madrillongroup.com
|
| Mary C Dufour, The Madrillon Group Inc, mdufour@madrillongroup.com
|
| Rachel Mandal, National Institutes of Health, mandalr@mail.nih.gov
|
| Stephan Philogene, National Institutes of Health, philogenes@mail.nih.gov
|
| Abstract:
Research center programs are an important tool used by the National Institutes of Health (NIH) to stimulate the growth of research investigation and infrastructure in emerging fields of scientific inquiry. Many evaluations of center programs focus on program outputs (publications, trainees trained, etc.) while neglecting outcomes. Few conceptual models exist to guide outcome assessment for these programs. One exception is the Research Payback Framework (RPF), an outcome-oriented case-study-based approach applied successfully in evaluations of biomedical and health research programs in Europe, Canada, and Australia. Since the RPF incorporates economic and non-economic outcomes, it can encompass the multiple objectives of NIH research centers. To the best of our knowledge, our study is the first application of the RPF framework with a US research center program. We describe its application with an NIH-funded research center program, including the conceptual and methodological enhancements we made and lessons learned to inform future applications.
|
| | |